Merck & Co. Stock - Analyst consensus stays at Moderate Buy
17.06.2026 - 21:20:03 | ad-hoc-news.de
Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/17/2026, 19:19 UTC. Details in the imprint.
Merck & Co. (US58933Y1055) remains firmly covered by Wall Street, with the stock carrying a Moderate Buy consensus from major brokerages based on the last 12 months of recommendations. MarketBeat aggregates 19 analyst ratings.
All news and analysis on Merck & Co. stock
From analyst targets and index moves to oncology data, this hub collects background and price information on Merck & Co. stock.
What analysts are signaling
According to MarketBeat, 19 Wall Street analysts currently rate Merck & Co. shares, with 12 Buys and 7 Holds, resulting in a consensus rating of Moderate Buy. The platform compiles the most recent recommendation from each firm.
The average 12-month price target stands at $128.18, implying roughly 11% upside from a reference price around $115 reported on the same page. The highest individual target reaches $150, while the lowest sits at $90.
How that compares across the market
The Moderate Buy stance places Merck alongside several large pharmaceutical peers that also trade with broadly positive but not unanimous analyst backing. A recent Globe and Mail note highlights differing views on major healthcare names.
All told, the spread between the highest and lowest targets underlines that analysts differ on how sustainable Merck's current growth, margins, and pipeline optionality will be over the next few years.
What the company sells
Merck & Co. generates most of its revenue from human health products, notably the cancer immunotherapy Keytruda for multiple tumor types and the HPV vaccine Gardasil, alongside a broader portfolio spanning vaccines, hospital acute-care drugs, and animal health.
Where the stock trades today
Merck & Co. shares (US58933Y1055) trade on the New York Stock Exchange at $115.25 as of 06/17/2026, 19:10 ET.
Key facts on Merck & Co. stock
- Company: Merck & Co., Inc.
- ISIN: US58933Y1055
- WKN: A3EEH3
- Ticker: MRK
- Venue: NYSE
- Price (as of 06/17/2026, 19:10 ET): 115.25 USD
- Market cap: 283,000,000,000 USD (as of 06/17/2026)
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: Dow Jones Industrial Average, S&P 500
- Next earnings date: 07/25/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
